Neuralink Plans 20,000 Surgical Implants per Year
By Reuters | 23 Jul, 2025
Five clinics implanting three devices will drive $1 billion annual revenues by 2031 according to investor documents released by Elon Musk's Neuralink.
A 3D-printed miniature model of Elon Musk and the Neuralink logo are seen in this illustration taken January 23, 2025. REUTERS/Dado Ruvic/Illustration/File Photo
Elon Musk's brain implant company Neuralink aims to generate at least $1 billion in annual revenue by 2031, driven by plans to perform 20,000 surgeries per year, Bloomberg News reported on Wednesday, citing investor documents.
The company aims to operate five large clinics within six years and offer three versions of its brain device, including Telepathy for communication between the brain and machines, Blindsight for restoring vision, and Deep for treating tremors and Parkinson's disease, according to the report.
Neuralink did not immediately respond to a Reuters request for comment.
The company expects regulatory approval for its Telepathy device by 2029, with plans to perform 2,000 surgeries annually and generate $100 million in revenue, the report said. By 2030, Neuralink anticipates launching Blindsight, expanding surgeries to 10,000 per year and generating over $500 million in revenue.
(Reporting by Kamal Choudhury in Bengaluru; Editing by Anil D'Silva)
Recent Articles
- How Don Can Make the US and the World Whole at the Beijing Summit
- Trump Plans Smaller CEO Delegation to Beijing Summit
- US Image Sinks Below Russia's Under Trump, Survey Finds
- Stellantis, Leapmotor to Become Joint Venture in Europe EV Production
- Sony, TSMC Plan New Japan Joint Venture for Next-Generation Image Sensors
- Chinese Fireworks Makers See Trump Visit Auguring Spectacular July 4 Celebrations
- Hybrid Car Sales Soar in US Along with Gas Prices
- Trump Crackdown on China-Linked Solar Firms Stalls US Factory Boom
- DOGE Termination of 1,400 Humanities Grants Were Unlawful, Discriminatory
- Trump Insists Ceasefire Still Holds Despite Fresh Strikes by Both Sides
